Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) on Monday, plunged -10.48% from the previous trading day, before settling in for the closing price of $0.38. Within the past 52 weeks, QNRX’s price has moved between $0.36 and $6.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 78.42%. With a float of $1.12 million, this company’s outstanding shares have now reached $5.05 million.
Considering the fact that the conglomerate employs 4 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 50.81%, operating margin of -5948.33%, and the pretax margin is -5648.18%.
Quoin Pharmaceuticals Ltd ADR (QNRX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The most recent insider transaction that took place on Dec 23 ’24, was worth 250,000. In this transaction Chief Operating Officer of this company bought 555,556 shares at a rate of $0.45, taking the stock ownership to the 602,648 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Executive Officer bought 555,556 for $0.45, making the entire transaction worth $250,000. This insider now owns 602,808 shares in total.
Quoin Pharmaceuticals Ltd ADR (QNRX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 78.42% per share during the next fiscal year.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Trading Performance Indicators
Quoin Pharmaceuticals Ltd ADR (QNRX) is currently performing well based on its current performance indicators. A quick ratio of 3.02 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.08, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of Quoin Pharmaceuticals Ltd ADR (QNRX)
Compared to the last year’s volume of 4.68 million, its volume of 14.03 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 3.72%. Additionally, its Average True Range was 0.09.
During the past 100 days, Quoin Pharmaceuticals Ltd ADR’s (QNRX) raw stochastic average was set at 0.08%, which indicates a significant decrease from 0.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 150.49% in the past 14 days, which was lower than the 158.50% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6212, while its 200-day Moving Average is $0.6468. Nevertheless, the first resistance level for the watch stands at $0.3612 in the near term. At $0.3814, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.3920. If the price goes on to break the first support level at $0.3304, it is likely to go to the next support level at $0.3198. Now, if the price goes above the second support level, the third support stands at $0.2996.
Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX) Key Stats
Market capitalization of the company is 1.72 million based on 5,050K outstanding shares. Right now, sales total 0 K and income totals -8,690 K. The company made 0 K in profit during its latest quarter, and -2,350 K in sales during its previous quarter.
